{"title":"Repenser la formation médicale pour répondre aux enjeux actuels.","authors":"Raphaël Bonvin","doi":"10.53738/REVMED.2025.21.902.152","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.902.152","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 902","pages":"152"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Virginie Tacchini, Christina Gkotsoulia, Adelin Barrier, Nicolas Johner, Dipen Shah, Haran Burri, Georg Ehret, Elena Tessitore, Marco Roffi, François Mach
{"title":"[Cardiology. Rhythmology, hypertension, dyslipidemia and aortic diseases].","authors":"Virginie Tacchini, Christina Gkotsoulia, Adelin Barrier, Nicolas Johner, Dipen Shah, Haran Burri, Georg Ehret, Elena Tessitore, Marco Roffi, François Mach","doi":"10.53738/REVMED.2025.21.902.119","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.902.119","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is common and its treatment is complex. The new European guidelines emphasize a patient-centered approach, considering the risk factors that contribute to AF and their management in primary and secondary prevention. Recent advances in electrophysiology include the development of new ablation techniques and the implantation of a leadless bicameral pacemaker. Similarly, the management of cardiovascular risk factors is evolving with new recommendations for hypertension and hypercholesterolemia. Finally, new biological markers are included in assessing overall cardiovascular risk. This article reviews recent advances in cardiology, including electrophysiology, cardiovascular prevention, and aortic disease.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 902","pages":"119-125"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Gastroenterology and hepatology : what's new in 2024].","authors":"Océane Gasser, Paraskevi Archanioti, Matteo Marasco, Giulia Piazza, Lauriane Mesureur, Sarra Souiai, Anca Teodora Antonino, Jean-François Dufour, Domenico Galasso","doi":"10.53738/REVMED.2025.21.902.131","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.902.131","url":null,"abstract":"<p><p>The year 2024 was rich in developments in the field of hepatology, gastroenterology, and interventional endoscopy. New molecules have been developed for the treatment of metabolic steatohepatitis, primary biliary cirrhosis, and inflammatory bowel diseases. Technological progress now makes it possible to perform screening measurements for portal hypertension directly under echo-endoscopic guidance and to extend the use of intraluminal stents to surgically modified anatomies. Several new recommendations have also been issued, including some for the nutritional management of inflammatory diseases, the management of polypoid lesions, and intraductal papillary mucinous neoplasms.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 902","pages":"131-135"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Évolution du risque cardiovasculaire après l’arrêt du tabac.","authors":"Gaël Grandmaison","doi":"10.53738/REVMED.2025.21.902.150","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.902.150","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 902","pages":"150"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Thierry Favrod-Coune, Isabelle Cordonier, Griselda Ortiz de Zarate, Déborah Lidsky
{"title":"[Gender and substance use : men exposed, women vulnerable].","authors":"Thierry Favrod-Coune, Isabelle Cordonier, Griselda Ortiz de Zarate, Déborah Lidsky","doi":"10.53738/REVMED.2025.21.902.97","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.902.97","url":null,"abstract":"<p><p>The use of psychoactive substances affects more men than women, with a prevalence that is 1.3 to 2 times higher, except for the use of sedatives. Men are also more affected by accidents, injuries, and acts of violence. As for women, they are more vulnerable to the consequences of substance use for metabolic, hormonal, and cerebral reasons. At the same time, they suffer more psychological problems, somatic complications, and exposure to violence. Sociocultural representations may prevent them from expressing their difficulties and delay their entry into care. It is essential to understand these gender differences in order to take action to reduce the prevalence of substance use among men and to facilitate early detection and treatment among women, particularly around the time of pregnancy.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 902","pages":"97-101"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Integrative medicine : what's new in 2024].","authors":"Caitriona Ungarelli-McEvoy, Mercedes Ogal, Mapi Fleury, Marc Schlaeppi, Chantal Berna, Noëmi Zurron, Aurore Fernandez","doi":"10.53738/REVMED.2025.21.900-1.53","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.900-1.53","url":null,"abstract":"<p><p>This article reports on new findings on integrative and complementary medicine published in 2024. The implementation of guidelines for the management of pain in cancer patients is discussed. Then, a literature review is presented, that aims to clarify the role of complementary approaches in the management of chemotherapy-induced nausea and vomiting and provides a concrete example of how recommendations are established. Finally, a meta-analysis focusing on the efficacy of Echinacea in the treatment of upper respiratory tract infections is summarized. These articles illustrate the complexity of the path from science to practice and underscore the importance of identifiable centers of reference to support the dissemination of knowledge to health care professionals and promote broad patient access to well-coordinated therapies.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 900-1","pages":"53-55"},"PeriodicalIF":0.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Pneumology : what's new in 2024].","authors":"Frédéric Lador, Pieter-Jan Gijs, Léon Genecand, Radhika Sood, Caroline Rayroux, Romain Messe, Ivan Guerreiro, John-David Aubert","doi":"10.53738/REVMED.2025.21.900-1.67","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.900-1.67","url":null,"abstract":"<p><p>In 2024, several important innovations have enriched the management of respiratory diseases, including pulmonary hypertension, tuberculosis, COPD, and obstructive sleep apnea syndrome (OSAS). Notable advancements include the introduction of sotatercept in Switzerland for pulmonary arterial hypertension and mediastinal cryobiopsies, reflecting a shift toward more personalized medicine. Meanwhile, biologic therapies for COPD offer promising perspectives, and a potential path is emerging for shortening the treatment of certain forms of tuberculosis. These developments open the door to new therapeutic options, with the hope of enhancing care and delivering meaningful clinical benefits to patients.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 900-1","pages":"67-72"},"PeriodicalIF":0.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bénédicte Le Tinier, Rita Kallab, Georges Savoldelli, Begoña Martinez De Tejada
{"title":"[Gynecology-obstetrics. Contribution of maternal haemodynamics during pregnancy].","authors":"Bénédicte Le Tinier, Rita Kallab, Georges Savoldelli, Begoña Martinez De Tejada","doi":"10.53738/REVMED.2025.21.900-1.34","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.900-1.34","url":null,"abstract":"<p><p>Pregnancy leads to a progressive adaptation of the maternal vascular and cardiac systems. Blood pressure is an imperfect indicator of this adaptation, as it reflects cardiac output, vascular resistance, and circulatory volume. Increasingly, studies show that poor hemodynamic adaptation can predict or accompany maternal and/or foetal complications. During pregnancy follow-up, assessing hemodynamic parameters could help identify patients at-risk and personalize their care. In obstetric emergencies, understanding the maternal hemodynamic status can improve clinical management.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 900-1","pages":"34-40"},"PeriodicalIF":0.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
求助内容：
应助结果提醒方式：